Our previous research on PI3Kγ inhibition highlighted the ability of HNSCC tumors to promote PD-L1 expression in the tumor microenvironment as a potential mechanism to evade the favorable immune response elicited by PI3Kγ inhibition.17 The gene discussed is CD274; the disease is neoplasm.